The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study

Published:2021-06 Issue:6 Volume:84 Page:1762-1764
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Dika Emi,Mastroeni Simona,Lambertini Martina,Scarfì Federica,Patrizi Annalisa,Veronesi Giulia,Magnaterra Elisabetta,Borghi Alessandro,Corazza Monica,Diemberger Igor,Poluzzi Elisabetta,Fortes Cristina

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Photosensitizing medication use and risk of skin cancer;Kaae;Cancer Epidemiol Biomarkers Prev,2010

2. Use of antiepileptic drugs and risk of skin cancer: a nationwide case-control study;Kristensen;J Am Acad Dermatol,2020

3. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis;Gandini;Crit Rev Oncol Hematol,2018

4. Gender medicine and oncology: report and consensus of an ESMO workshop;Wagner;Ann Oncol,2019

5. Drug-induced photosensitivity-an update: culprit drugs, prevention and management;Blakely;Drug Saf,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling hydrochlorothiazide: Skin cancer risk and hidden interactions;Journal of the American Academy of Dermatology;2023-11

2. Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark;Frontiers in Pharmacology;2022-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP